FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888970830> ?p ?o ?g. }

• W2888970830 endingPage "166" @default.
• W2888970830 startingPage "159" @default.
• W2888970830 abstract "Objective To assess the accuracy of the National Institute of Health and Care Excellence (NICE) and United States Preventive Services Task Force (USPSTF) guidelines for predicting pre-eclampsia in pregnancy to guide aspirin prophylaxis. Study design We conducted an individual participant data meta-analysis using the Perinatal Antiplatelet Review of International Studies (PARIS) dataset. This dataset includes randomised controlled trials (RCTs) of antiplatelet therapy for primary prevention of pre-eclampsia conducted in international antenatal care settings. RCTs were eligible if they enrolled pregnant women up to 28 weeks’gestation, reported risk factors, and assessed pre-eclampsia. Women assigned to the control arm (no antiplatelet agent) were included. Both guidelines recommend aspirin if ≥1 high-risk factors or ≥2 moderate-risk factors. Two moderate-risk factors (body mass index and pregnancy interval) were unavailable. Pre-eclampsia was the primary outcome. The secondary outcomes were pre-eclampsia defined by gestational age at delivery (<37 weeks versus ≥37 weeks; <34 weeks versus ≥34 weeks). We assessed the performance of the NICE and USPSTF approaches for parous and nulliparous women by estimating sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for predicting pre-eclampsia, the number-needed-to-screen (NNS) and the number-needed-to-treat (NNT) to prevent one pre-eclampsia event. Results Three RCTs were eligible (4524 women, 221 pre-eclampsia cases). Using the NICE guidelines, 9.4% of 1020 parous women were classified as screen-positive with a sensitivity of 26.4% (95% confidence interval 16.4–39.6%), specificity 91.5% (89.6–93.1%), PPV 14.6% (8.9–23.0%) and NPV 95.8% (94.3–96.9%). The NNS was 729 and NNT 69. For 3504 nulliparous women, 3% were classified as screen-positive with a sensitivity of 8.9% (5.5–14.4%), specificity 97.2% (96.6–97.8%), PPV 14.2% (8.7–21.9%), NPV 95.5% (94.8–96.1%). The NNS was 2336 and NNT 71. The USPSTF approach demonstrated similar performance. Conclusion The NICE and USPSTF guidelines offer a simple and specific approach for recommending aspirin prophylaxis for women at high-risk of pre-eclampsia where more advanced screening methods are not available. However, the low detection rate limits its value in clinical practice, in particular for nulliparous women, and raises the need for development of an improved simple risk prediction tool." @default.
• W2888970830 created "2018-09-07" @default.
• W2888970830 creator A5001067933 @default.
• W2888970830 creator A5007364467 @default.
• W2888970830 creator A5037149980 @default.
• W2888970830 creator A5045578991 @default.
• W2888970830 creator A5052465499 @default.
• W2888970830 creator A5074877527 @default.
• W2888970830 date "2018-10-01" @default.
• W2888970830 modified "2023-09-30" @default.
• W2888970830 title "Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis" @default.
• W2888970830 cites W1975280744 @default.
• W2888970830 cites W1994682257 @default.
• W2888970830 cites W2000135242 @default.
• W2888970830 cites W2010464774 @default.
• W2888970830 cites W2044192971 @default.
• W2888970830 cites W2059849249 @default.
• W2888970830 cites W2080780491 @default.
• W2888970830 cites W2085996860 @default.
• W2888970830 cites W2112669742 @default.
• W2888970830 cites W2123627435 @default.
• W2888970830 cites W2127608785 @default.
• W2888970830 cites W2152401910 @default.
• W2888970830 cites W2156831284 @default.
• W2888970830 cites W2157381327 @default.
• W2888970830 cites W2167675201 @default.
• W2888970830 cites W2169160087 @default.
• W2888970830 cites W2290272811 @default.
• W2888970830 cites W2318239034 @default.
• W2888970830 cites W2331291442 @default.
• W2888970830 cites W2340668831 @default.
• W2888970830 cites W2346358422 @default.
• W2888970830 cites W2404753452 @default.
• W2888970830 cites W2520664488 @default.
• W2888970830 cites W2592251773 @default.
• W2888970830 cites W2738649869 @default.
• W2888970830 cites W2751426555 @default.
• W2888970830 cites W2767859123 @default.
• W2888970830 cites W2781814244 @default.
• W2888970830 cites W2790948098 @default.
• W2888970830 cites W2793247028 @default.
• W2888970830 cites W2808237135 @default.
• W2888970830 cites W3160565403 @default.
• W2888970830 cites W4243714175 @default.
• W2888970830 doi "https://doi.org/10.1016/j.ejogrb.2018.08.587" @default.
• W2888970830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30199814" @default.
• W2888970830 hasPublicationYear "2018" @default.
• W2888970830 type Work @default.
• W2888970830 sameAs 2888970830 @default.
• W2888970830 citedByCount "19" @default.
• W2888970830 countsByYear W28889708302019 @default.
• W2888970830 countsByYear W28889708302020 @default.
• W2888970830 countsByYear W28889708302021 @default.
• W2888970830 countsByYear W28889708302022 @default.
• W2888970830 countsByYear W28889708302023 @default.
• W2888970830 crossrefType "journal-article" @default.
• W2888970830 hasAuthorship W2888970830A5001067933 @default.
• W2888970830 hasAuthorship W2888970830A5007364467 @default.
• W2888970830 hasAuthorship W2888970830A5037149980 @default.
• W2888970830 hasAuthorship W2888970830A5045578991 @default.
• W2888970830 hasAuthorship W2888970830A5052465499 @default.
• W2888970830 hasAuthorship W2888970830A5074877527 @default.
• W2888970830 hasConcept C126322002 @default.
• W2888970830 hasConcept C131872663 @default.
• W2888970830 hasConcept C168563851 @default.
• W2888970830 hasConcept C199360897 @default.
• W2888970830 hasConcept C2777628954 @default.
• W2888970830 hasConcept C2779234561 @default.
• W2888970830 hasConcept C2779256446 @default.
• W2888970830 hasConcept C2781276381 @default.
• W2888970830 hasConcept C41008148 @default.
• W2888970830 hasConcept C44249647 @default.
• W2888970830 hasConcept C54355233 @default.
• W2888970830 hasConcept C71924100 @default.
• W2888970830 hasConcept C86803240 @default.
• W2888970830 hasConceptScore W2888970830C126322002 @default.
• W2888970830 hasConceptScore W2888970830C131872663 @default.
• W2888970830 hasConceptScore W2888970830C168563851 @default.
• W2888970830 hasConceptScore W2888970830C199360897 @default.
• W2888970830 hasConceptScore W2888970830C2777628954 @default.
• W2888970830 hasConceptScore W2888970830C2779234561 @default.
• W2888970830 hasConceptScore W2888970830C2779256446 @default.
• W2888970830 hasConceptScore W2888970830C2781276381 @default.
• W2888970830 hasConceptScore W2888970830C41008148 @default.
• W2888970830 hasConceptScore W2888970830C44249647 @default.
• W2888970830 hasConceptScore W2888970830C54355233 @default.
• W2888970830 hasConceptScore W2888970830C71924100 @default.
• W2888970830 hasConceptScore W2888970830C86803240 @default.
• W2888970830 hasLocation W28889708301 @default.
• W2888970830 hasLocation W28889708302 @default.
• W2888970830 hasOpenAccess W2888970830 @default.
• W2888970830 hasPrimaryLocation W28889708301 @default.
• W2888970830 hasRelatedWork W1993079004 @default.
• W2888970830 hasRelatedWork W2001631557 @default.
• W2888970830 hasRelatedWork W2043432888 @default.
• W2888970830 hasRelatedWork W2060432109 @default.
• W2888970830 hasRelatedWork W2064286441 @default.
• W2888970830 hasRelatedWork W2093828693 @default.

• next